Dr-Thomas-Seck

Thomas Seck, M.D., vice president Clinical Development and Medical Affairs, Primary Care Boehringer Ingelheim Pharmaceuticals, Inc.

Dr. Thomas Seck

RSS
Facebook
Facebook
Google+
https://medicalresearch.com/author-interviews/idarucizumab-praxbind-reverse-anticoagulant-effect-of-pradaxa-prior-to-emergency-surgery/38544/attachment/dr-thomas-seck/

Thomas Seck, M.D., vice president
Clinical Development and Medical Affairs, Primary Care
Boehringer Ingelheim Pharmaceuticals, Inc.

RSS
Facebook
Facebook
Google+
https://medicalresearch.com/author-interviews/idarucizumab-praxbind-reverse-anticoagulant-effect-of-pradaxa-prior-to-emergency-surgery/38544/attachment/dr-thomas-seck/

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.